Puma Biotechnology, Inc. (PBYI) total debt

Total debt · fiscal 2025
$28.55M

Puma Biotechnology, Inc. (PBYI) carried total debt of $28.55M at the end of fiscal 2025 (December 31, 2025). That is 61.5% lower than the $74.08M of fiscal 2024. Figures as of 18 Nov 2026, 11:14 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$28.55M
Change on fiscal 2024
−61.5%
Growth, 5 years
−21.9% a year
Highest on record
$151.89Mfiscal 2018
Lowest on record
$28.55Mfiscal 2025
Fiscal years on record
92017–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Puma Biotechnology, Inc. total debt, in more detail

Over the five fiscal years to 2025 total debt shrank at a compound 21.9% a year. Across the 9 fiscal years on record (2017–2025), the highest was $151.89M in fiscal 2018 and the lowest $28.55M in fiscal 2025.

Total debt was 0.2× shareholders' equity at the end of fiscal 2025.

History · 9 fiscal years

Total debt by fiscal year

Puma Biotechnology, Inc. total debt, year by year

Puma Biotechnology, Inc. (PBYI) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$28.55M 61.5% down0.2×
2024$74.08M 33.6% down0.8×
2023$111.49M 2.4% down2.1×
2022$114.28M 12.0% up5.3×
2021$102.00M 3.8% up—
2020$98.31M 3.5% up—
2019$94.96M 37.5% down5.4×
2018$151.89M 213.3% up4.4×
2017$48.48M—0.9×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

More on PBYI

Puma Biotechnology, Inc., figure by figure

Puma Biotechnology, Inc. (PBYI) overview: price, valuation and scorecard

Puma Biotechnology, Inc. total debt: questions and answers

How much debt does Puma Biotechnology, Inc. have?

Puma Biotechnology, Inc. (PBYI) carried total debt of $28.55M at the end of fiscal 2025 (December 31, 2025). That is 61.5% lower than the $74.08M of fiscal 2024.

What is the growth rate of Puma Biotechnology, Inc.'s total debt?

Over the five fiscal years to 2025 total debt shrank at a compound 21.9% a year.

What are the highest and lowest total debt figures on record for Puma Biotechnology, Inc.?

Across the 9 fiscal years on record (2017–2025), the highest was $151.89M in fiscal 2018 and the lowest $28.55M in fiscal 2025.

How does Puma Biotechnology, Inc.'s debt compare with its equity?

Total debt was 0.2× shareholders' equity at the end of fiscal 2025.

How is Puma Biotechnology, Inc.'s total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative. For Puma Biotechnology, Inc. it is on record here for 9 fiscal years, 2017 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Puma Biotechnology, Inc. (PBYI) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/PBYI/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.